These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3306039)

  • 21. Plasma factors and platelet aggregation in diabetes mellitus.
    Colwell JA; Van Zile J; Kilpatrick JM; Nair RM; Virella G
    Horm Metab Res Suppl; 1981; 11():1-6. PubMed ID: 6976300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet membrane involvement in blood coagulation.
    Hemker HC; van Rijn JL; Rosing J; van Dieijen G; Bevers EM; Zwaal RF
    Blood Cells; 1983; 9(2):303-17. PubMed ID: 6661560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet factor 3: quantitation and characterization.
    Wu VY; McCoy LE
    Thromb Res; 1977 Nov; 11(5):581-93. PubMed ID: 929508
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of insulin on thrombocyte procoagulating activity].
    Puchin'ian DM
    Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):40-2. PubMed ID: 6997863
    [No Abstract]   [Full Text] [Related]  

  • 25. [Platelet hyperaggregation and plasma hypercoagulability associated with normal antithrombin III and platelet factor 3 deficiency in the nephrotic syndrome in children].
    Cutcudache C; Boldescu G; Antal C; Chirică A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):57-66. PubMed ID: 6145206
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood coagulation tests for plasma factors. Tatsumi factor].
    Umegaki K
    Rinsho Byori; 1969; 16():Suppl 16:105+. PubMed ID: 5391581
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma fractionation with special reference to the treatment of coagulation disorders.
    Bidwell E
    Proc R Soc Med; 1968 Jun; 61(6):598-600. PubMed ID: 5662213
    [No Abstract]   [Full Text] [Related]  

  • 28. [Release and determination of blood platelet factor 4].
    Wamhoff D
    Z Gesamte Inn Med; 1974 Jun; 29(12):487-90. PubMed ID: 4849602
    [No Abstract]   [Full Text] [Related]  

  • 29. Sources of variability in coagulation factor assays.
    Thompson SG; Martin JC; Meade TW
    Thromb Haemost; 1987 Dec; 58(4):1073-7. PubMed ID: 3445225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Platelet factor IV (antiheparin factor) and various disease states].
    Ulutin ON; Akman N
    Turk Tip Cemiy Mecm; 1967 Jan; 33(1):61-5. PubMed ID: 6066642
    [No Abstract]   [Full Text] [Related]  

  • 31. The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.
    Appiani AC; Edefonti A; Bettinelli A; Cossu MM; Paracchini ML; Rossi E
    Clin Nephrol; 1982 Apr; 17(4):195-9. PubMed ID: 6176380
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet factor release following heparin administration and during extracorporeal circulation.
    Flicker W; Milthorpe BK; Schindhelm K; Odell RA; McPherson J; Farrell PC
    Trans Am Soc Artif Intern Organs; 1982; 28():431-6. PubMed ID: 6219490
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
    Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
    Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
    [No Abstract]   [Full Text] [Related]  

  • 34. An accurate assay for platelet factor 3.
    Speck RE
    Am Clin Lab; 1993 Sep; 12(9):16-8. PubMed ID: 10146407
    [No Abstract]   [Full Text] [Related]  

  • 35. [A basic and clinical study on platelet factor 4 (PF4)].
    Satoh M; Endo Y; Mamiya S
    Rinsho Byori; 1982 Jun; 30(6):673-7. PubMed ID: 7131839
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased platelet factor 3 activity in Plasmodium falciparum malaria.
    Emuchay CI; Usanga EA
    East Afr Med J; 1997 Aug; 74(8):527-9. PubMed ID: 9487421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies of platelet factor-3 by the kaolin clotting time and thromboplastin generation time].
    Oki H; Takashima A
    Rinsho Byori; 1973 Jul; 21(7):621-6. PubMed ID: 4738067
    [No Abstract]   [Full Text] [Related]  

  • 38. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group].
    Kertscher HP; Ostermann G
    Pharmazie; 1987 Nov; 42(11):713-5. PubMed ID: 3438334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of platelet factor IV for the evaluation of platelet function in patients with ischemic cardiopathy].
    de Teresa E; Lorenz MP; Vera A; Ortigosa J; Chamorro JL; de Artaza M
    Rev Esp Cardiol; 1981; 34(4):311-5. PubMed ID: 7323384
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet activation and allergic asthma.
    Gresele P; Todisco T; Merante F; Nenci GG
    N Engl J Med; 1982 Mar; 306(9):549. PubMed ID: 6173752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.